COVID, RT-ddPCR Multiplex
Conditions
Brief summary
The objective of the study is to develop and validate a molecular diagnostic strategy (RT-ddPCR multiplex) of COVID-19 based on a saliva sample and alternative to the RT-qPCR method, in order to : 1. to compensate for the risk of a shortage of diagnostic kits, reagents and materials necessary for molecular diagnosis; 2. to increase the molecular diagnostic capacity of COVID-19 at the Rouen University Hospital; 3. and to have a method compatible with screening extended to populations at risk.
Interventions
Saliva collection will be done in addition to standard diagnosis collection (nasopharyngeal collection using swab)
Sponsors
Study design
Eligibility
Inclusion criteria
* Person aged over 18 years presenting to the COVID-19 consultation of the Rouen University Hospital for screening * Person affiliated to a social security scheme
Exclusion criteria
* Person objecting to participation in the research after reading information * Person under the protection of justice, * Person deprived of their liberty by administrative or judicial decision (guardianship, curatorship, etc.) * Patient under guardianship or curatorship
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Number of positive patient using saliva method compared to number of positive patient using standard method | One hour |
| Number of negative patient using saliva method compared to number of negative patient using standard method | One hour |
Countries
France
Contacts
University Hospital, Rouen